Teva Pharmaceutical Industries Limited (NYSE:TEVA)‘s stock had its “neutral” rating reiterated by Mizuho in a research note issued on Friday. They currently have a $12.00 price target on the stock, down from their prior price target of $15.00. Mizuho’s price target would suggest a potential downside of 13.29% from the stock’s previous close.

TEVA has been the topic of several other reports. Credit Suisse Group reissued an “underperform” rating and issued a $8.00 price objective (down from $14.00) on shares of Teva Pharmaceutical Industries Limited in a research note on Monday, November 6th. Royal Bank Of Canada dropped their price objective on shares of Teva Pharmaceutical Industries Limited from $21.00 to $15.00 and set an “underperform” rating on the stock in a research note on Monday, September 18th. Wells Fargo & Company reissued a “market perform” rating on shares of Teva Pharmaceutical Industries Limited in a research note on Thursday, October 5th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Teva Pharmaceutical Industries Limited in a research note on Sunday, November 12th. Finally, Maxim Group reissued a “hold” rating and issued a $15.50 price objective on shares of Teva Pharmaceutical Industries Limited in a research note on Thursday, September 14th. Seven analysts have rated the stock with a sell rating, seventeen have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Teva Pharmaceutical Industries Limited presently has an average rating of “Hold” and a consensus target price of $21.88.

Shares of Teva Pharmaceutical Industries Limited (TEVA) opened at $13.84 on Friday. The firm has a market cap of $14,061.44, a P/E ratio of 3.20 and a beta of 0.52. The company has a current ratio of 0.96, a quick ratio of 0.66 and a debt-to-equity ratio of 1.20. Teva Pharmaceutical Industries Limited has a 12-month low of $10.85 and a 12-month high of $39.08.

WARNING: “Teva Pharmaceutical Industries Limited (TEVA) Rating Reiterated by Mizuho” was published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/11/19/teva-pharmaceutical-industries-limited-teva-rating-reiterated-by-mizuho.html.

Institutional investors and hedge funds have recently made changes to their positions in the stock. San Francisco Sentry Investment Group CA bought a new position in Teva Pharmaceutical Industries Limited during the second quarter worth $106,000. Kistler Tiffany Companies LLC lifted its stake in Teva Pharmaceutical Industries Limited by 74.7% in the second quarter. Kistler Tiffany Companies LLC now owns 3,673 shares of the company’s stock valued at $122,000 after buying an additional 1,571 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in Teva Pharmaceutical Industries Limited by 2.6% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,711 shares of the company’s stock valued at $123,000 after buying an additional 94 shares during the last quarter. Cutler Capital Management LLC bought a new stake in Teva Pharmaceutical Industries Limited in the second quarter valued at $133,000. Finally, Shelter Mutual Insurance Co bought a new stake in Teva Pharmaceutical Industries Limited in the second quarter valued at $133,000. Hedge funds and other institutional investors own 55.81% of the company’s stock.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Analyst Recommendations for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Receive News & Ratings for Teva Pharmaceutical Industries Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries Limited and related companies with MarketBeat.com's FREE daily email newsletter.